Effect of strontium ranelate on hydrogen peroxide-induced apoptosis of CRL-11372 cells

Biochemical Genetics

Volumn 46, Issue 3-4, 2008, Pages 197-205

  Senkoylu, Alpaslan ^a   Yilmaz, Akin ^a   Ergun, Mehmet Ali ^a   İlhan, Mustafa N ^a   Simsek, Aykin ^a   Altun, Necdet ^a   Bolukbasi, Selcuk ^a   Menevse, Sevda ^a  

^a GAZI UNIVERSITY FACULTY OF MEDICINE   (Turkey)

Author keywords

Apoptosis; Osteoblast; Strontium ranelate; Tissue culture

Indexed keywords

AGAROSE; FLUORESCENT DYE; HYDROGEN PEROXIDE; STRONTIUM RANELATE;

AGAR GEL ELECTROPHORESIS; APOPTOSIS; ARTICLE; CELL LINE; CELL VIABILITY; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; DOSE RESPONSE; DRUG EFFECT; EXPERIMENT; HUMAN; HUMAN CELL; OSTEOBLAST; QUALITATIVE ANALYSIS; QUANTITATIVE ANALYSIS; STATISTICAL SIGNIFICANCE;

EID: 43449132107     PISSN: 00062928     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10528-008-9142-1     Document Type: Article

References (28)

1. A Barbara P Delannoy BG Denis PJ Marie 2004 Normal matrix mineralization induced by strontium ranelate in MC3T3-E1 osteogenic cells Metabolism 53 532 537 15045704 10.1016/j.metabol.2003.10.022 1:CAS:528:DC%2BD2cXisVSlsrc%3D Barbara A, Delannoy P, Denis BG, Marie PJ (2004) Normal matrix mineralization induced by strontium ranelate in MC3T3-E1 osteogenic cells. Metabolism 53:532–537
2. R Baron Y Tsouderos 2002 In vitro effects of S12911-2 on osteoclast function and bone marrow macrophage differentiation Eur J Pharmacol 450 11 17 12176103 10.1016/S0014-2999(02)02040-X 1:CAS:528:DC%2BD38XmtlKjsb8%3D Baron R, Tsouderos Y (2002) In vitro effects of S12911-2 on osteoclast function and bone marrow macrophage differentiation. Eur J Pharmacol 450:11–17
3. EM Brown 2003 Is the calcium receptor a molecular target for the actions of strontium on bone Osteoporosis Int 14 Suppl. 3 S25 S34 1:CAS:528:DC%2BD3sXjslWhs7o%3D Brown EM (2003) Is the calcium receptor a molecular target for the actions of strontium on bone. Osteoporosis Int 14(Suppl. 3):S25–S34
4. E Canalis M Hott P Deloffre Y Tsouderos PJ Marie 1996 The divalent strontium salt S12911 enhances bone cell replication and bone formation in vitro Bone 18 517 523 8805991 10.1016/8756-3282(96)00080-4 1:CAS:528:DyaK28Xkslagu7k%3D Canalis E, Hott M, Deloffre P, Tsouderos Y, Marie PJ (1996) The divalent strontium salt S12911 enhances bone cell replication and bone formation in vitro. Bone 18:517–523
5. CC Chua BH Chua Z Chen C Landy RC Hamdy 2003 Dexamethasone induces caspase activation in murine osteoblastic MC3T3-E1 cells Biochim Biophys Acta 1642 79 85 12972296 10.1016/S0167-4889(03)00100-9 1:CAS:528:DC%2BD3sXntVeqtro%3D Chua CC, Chua BH, Chen Z, Landy C, Hamdy RC (2003) Dexamethasone induces caspase activation in murine osteoblastic MC3T3-E1 cells. Biochim Biophys Acta 1642:79–85
6. P Delannoy D Bazot PJ Marie 2002 Long-term treatment with strontium ranelate increases vertebral bone mass without deleterious effect in mice Metabolism 51 906 911 12077740 10.1053/meta.2002.33360 1:CAS:528:DC%2BD38Xlt1Slt7k%3D Delannoy P, Bazot D, Marie PJ (2002) Long-term treatment with strontium ranelate increases vertebral bone mass without deleterious effect in mice. Metabolism 51:906–911
7. J Gong F Traganos Z Darzynkiewicz 1994 A selective procedure for DNA extraction from apoptotic cells applicable for gel electrophoresis and flow cytometry Anal Biochem 218 314 319 8074286 10.1006/abio.1994.1184 1:CAS:528:DyaK2cXivFensrg%3D Gong J, Traganos F, Darzynkiewicz Z (1994) A selective procedure for DNA extraction from apoptotic cells applicable for gel electrophoresis and flow cytometry. Anal Biochem 218:314–319
8. MD Grynpas PJ Marie 1990 Effects of low doses of strontium on bone quality and bone quantity in rats Bone 11 313 319 2252809 10.1016/8756-3282(90)90086-E 1:CAS:528:DyaK3MXksVyjtbo%3D Grynpas MD, Marie PJ (1990) Effects of low doses of strontium on bone quality and bone quantity in rats. Bone 11:313–319
9. SA Harris RJ Enger BL Riggs TC Spelsberg 1995 Development and characterization of a conditionally immortalized human fetal osteoblastic cell line J Bone Miner Res 10 178 186 7754797 1:STN:280:DyaK2M3nsVCitA%3D%3D Harris SA, Enger RJ, Riggs BL, Spelsberg TC (1995). Development and characterization of a conditionally immortalized human fetal osteoblastic cell line. J Bone Miner Res 10:178–186
10. M Hott P Deloffre Y Tsouderos PJ Marie 2003 S12911-2 reduces bone loss induced by short-term immobilization in rats Bone 33 115 123 12919706 10.1016/S8756-3282(03)00115-7 1:CAS:528:DC%2BD3sXmt1Kjsb8%3D Hott M, Deloffre P, Tsouderos Y, Marie PJ (2003) S12911-2 reduces bone loss induced by short-term immobilization in rats. Bone 33:115–123
11. AS Hurtel-Lemaire R Mentaverri A Wattel S Kamel M Brazier 2005 Proteinkinases C are involved in strontium ranelate-induced osteoclast apoptosis Bone 36 Suppl. 2 S403 Hurtel-Lemaire AS, Mentaverri R, Wattel A, Kamel S, Brazier M (2005) Proteinkinases C are involved in strontium ranelate-induced osteoclast apoptosis. Bone 36(Suppl. 2): S403
12. N Kovacić IK Lukić D Grcević V Katavić P Croucher A Marusić 2007 The Fas/Fas ligand system inhibits differentiation of murine osteoblasts but has a limited role in osteoblast and osteoclast apoptosis J Immunol 178 3379 3389 17339432 Kovacić N, Lukić IK, Grcević D, Katavić V, Croucher P, Marusić A (2007) The Fas/Fas ligand system inhibits differentiation of murine osteoblasts but has a limited role in osteoblast and osteoclast apoptosis. J Immunol 178:3379–3389
13. AL Liu ZM Zhang BF Zhu ZH Liao Z Liu 2004 Metallothionein protects bone marrow stromal cells against hydrogen peroxide-induced inhibition of osteoblastic differentiation Cell Biol Int 28 905 911 15566960 10.1016/j.cellbi.2004.09.004 1:CAS:528:DC%2BD2cXhtVWit7vK Liu AL, Zhang ZM, Zhu BF, Liao ZH, Liu Z (2004) Metallothionein protects bone marrow stromal cells against hydrogen peroxide-induced inhibition of osteoblastic differentiation. Cell Biol Int 28:905–911
14. PJ Marie M Hott D Modrowski C Pollak De J Guillemain P Deloffre Y Tsouderos 1993 An uncoupling agent containing strontium prevents bone loss by depressing bone resorption and maintaining bone formation in estrogen-deficient rats J Bone Miner Res 8 607 615 8511988 1:CAS:528:DyaK2cXksFSjsbs%3D 10.1002/jbmr.5650080512 Marie PJ, Hott M, Modrowski D, De Pollak C, Guillemain J, Deloffre P, Tsouderos Y (1993) An uncoupling agent containing strontium prevents bone loss by depressing bone resorption and maintaining bone formation in estrogen-deficient rats. J Bone Miner Res 8:607–615
15. PJ Marie P Ammann G Boivin C Rey 2001 Mechanisms of action and therapeutic potential of strontium in bone Calcif Tissue Int 69 121 129 11683526 10.1007/s002230010055 1:CAS:528:DC%2BD3MXnslCqur4%3D Marie PJ, Ammann P, Boivin G, Rey C (2001) Mechanisms of action and therapeutic potential of strontium in bone. Calcif Tissue Int 69:121–129
16. R Mentaverri AS Hurtel-Lemaire A Wattel S Kamel EM Brown M Brazier 2005 Calcium-sensing receptor mediates strontium ranelate-induced osteoclast apoptosis Bone 36 Suppl. 2 S403 Mentaverri R, Hurtel-Lemaire AS, Wattel A, Kamel S, Brown EM, Brazier M (2005) Calcium-sensing receptor mediates strontium ranelate-induced osteoclast apoptosis. Bone 36(Suppl. 2):S403
17. PJ Meunier DO Slosman PD Delmas JL Sebert ML Brandi C Albanese 2002 Strontium ranelate: dose-dependent effects on established postmenopausal vertebral osteoporosis: a 2-year randomized placebo controlled trial J Clin Endocrinol 87 2060 2066 10.1210/jc.87.5.2060 1:CAS:528:DC%2BD38XjsFGhtL4%3D Meunier PJ, Slosman DO, Delmas PD, Sebert JL, Brandi ML, Albanese C et al (2002) Strontium ranelate: dose-dependent effects on established postmenopausal vertebral osteoporosis: a 2-year randomized placebo controlled trial. J Clin Endocrinol 87:2060–2066
18. PJ Meunier C Roux E Seeman S Ortoloni JE Baduriski TD Spector J Cannata A Balogh EM Lemmel S Pors-Nielsen R Rizzoli HK Genant JY Reginster 2004 The effects of strontium ranelate on the risk of vertebral fracture in women with postmenopausel osteoporosis N Eng J Med 350 459 468 10.1056/NEJMoa022436 1:CAS:528:DC%2BD2cXos1Snsw%3D%3D Meunier PJ, Roux C, Seeman E, Ortoloni S, Baduriski JE, Spector TD, Cannata J, Balogh A, Lemmel EM, Pors-Nielsen S, Rizzoli R, Genant HK, Reginster JY (2004) The effects of strontium ranelate on the risk of vertebral fracture in women with postmenopausel osteoporosis. N Eng J Med 350:459–468
19. BY Park CI Yoo HT Kim CH Kwon YK Kim 2005 Role of mitogen-activated protein kinases in hydrogen peroxide-induced cell death in osteoblastic cells Toxicology 215 115 125 16125295 10.1016/j.tox.2005.07.003 1:CAS:528:DC%2BD2MXhtVymsbjL Park BY, Yoo CI, Kim HT, Kwon CH, Kim YK (2005) Role of mitogen-activated protein kinases in hydrogen peroxide-induced cell death in osteoblastic cells. Toxicology 215:115–125
20. K Qiu XJ Zhao CX Wan CS Zhao YW Chen 2006 Effect of strontium ions, on the growth of ROS17/2.8 cells on porous calcium polyphosphate scaffold Biomaterials 27 1277 1286 16143392 10.1016/j.biomaterials.2005.08.006 1:CAS:528:DC%2BD2MXht1Klu7nF Qiu K, Zhao XJ, Wan CX, Zhao CS, Chen YW (2006) Effect of strontium ions, on the growth of ROS17/2.8 cells on porous calcium polyphosphate scaffold. Biomaterials 27:1277–1286
21. JY Reginster 2002 Strontium ranelate in osteoporosis Curr Pharm Des 8 1907 1916 12171530 10.2174/1381612023393639 1:CAS:528:DC%2BD38Xmt1art7w%3D Reginster JY (2002) Strontium ranelate in osteoporosis. Curr Pharm Des 8:1907–1916
22. JY Reginster R Deroisy M Dougados I Jupsin J Colette C Roux 2002 Prevention of early postmenopausal bone loss by strontium ranelate: the randomized, two year, double masked, dose ranging, placebo-controlled PREVOS trial Osteoporos Int 13 925 931 12459934 10.1007/s001980200129 1:CAS:528:DC%2BD38XptFGitrc%3D Reginster JY, Deroisy R, Dougados M, Jupsin I, Colette J, Roux C (2002) Prevention of early postmenopausal bone loss by strontium ranelate: the randomized, two year, double masked, dose ranging, placebo-controlled PREVOS trial. Osteoporos Int 13:925–931
23. SM Swanson A Ijaz ML Fahning 1987 The use of acridine orange and ethidium bromide to determine the viability of pre-implantation mouse embryos cultured in vitro Br Vet J 143 306 311 2441794 1:STN:280:DyaL2szgtVKhug%3D%3D Swanson SM, Ijaz A, Fahning ML (1987) The use of acridine orange and ethidium bromide to determine the viability of pre-implantation mouse embryos cultured in vitro. Br Vet J 143:306–311
24. N Takahashi T Sasaki Y Tsouderos T Suda 2003 S12911-2 inhibits osteoclastic bone resorption in vitro J Bone Miner Res 18 1082 1087 12817762 10.1359/jbmr.2003.18.6.1082 1:CAS:528:DC%2BD3sXkslOhsbk%3D Takahashi N, Sasaki T, Tsouderos Y, Suda T (2003) S12911-2 inhibits osteoclastic bone resorption in vitro. J Bone Miner Res 18:1082–1087
25. M Tsuji H Ikeda A Ishizu Y Miyatake H Hayase T Yoshiki 2006 Altered expression of apoptosis-related genes in osteocytes exposed to high-dose steroid hormones and hypoxic stress Pathobiology. 73 304 309 17374968 10.1159/000099125 1:CAS:528:DC%2BD2sXjt1ygurY%3D Tsuji M, Ikeda H, Ishizu A, Miyatake Y, Hayase H, Yoshiki T (2006) Altered expression of apoptosis-related genes in osteocytes exposed to high-dose steroid hormones and hypoxic stress. Pathobiology. 73:304–309
26. SC Verberckmoes ME Broe De PC D’Haese 2003 Dose-dependent effects of strontium on osteoblast function and mineralization Kidney Int 64 534 543 12846748 10.1046/j.1523-1755.2003.00123.x 1:CAS:528:DC%2BD3sXmsFyku7g%3D Verberckmoes SC, De Broe ME, D’Haese PC (2003) Dose-dependent effects of strontium on osteoblast function and mineralization. Kidney Int 64:534–543
27. RS Weinstein SC Manolagas 2000 Apoptosis and osteoporosis Am J Med 108 153 164 11126309 10.1016/S0002-9343(99)00420-9 1:STN:280:DC%2BD3M%2Fns1GrtQ%3D%3D Weinstein RS, Manolagas SC (2000) Apoptosis and osteoporosis. Am J Med 108:153–164
28. Xie H, Tang SY, Li H, Luo XH, Yuan LQ, Wang D, Liao EY (2007) l-Carnitine protects against apoptosis of murine MC3T3-E1 osteoblastic cells. Amino Acids. 2007 Oct 2; [Epub ahead of print]